What an exciting year 2010 has been for the ARHP! We have made amazing progress in education, collaboration, and charting the ARHP’s future. To help you understand what the ARHP leadership and staff are doing on your behalf, I would like to share a few of our accomplishments from the past year.
Research Tracks Possible Benefit of Src-like Adaptor Protein
A study recently submitted for publication has demonstrated that manipulating T-cell receptor complex–mediated signaling can prevent the development of autoimmune arthritis in mice and may lead to new human therapies without the drawbacks associated with existing treatments.
A New Pain PILL: Lending a Personal Approach to Personalized Medicine
In caring for patients with chronic pain, I have tried all kinds of treatments to reduce bothersome symptoms, hoping to achieve improvements that are better than the usual one or two points on a visual analog scale. The list of these treatments is long—no doubt, you have tried the same ones—and include the expected array…
ACR launches its First Public Relations campaign
Many of us have experienced that look—confusion—when you tell someone that you work in rheumatology. It happens at dinner parties, in line at the grocery store, and during conversations on airplanes. The look can open the door to conversations about rheumatology. However, when the influential people whose decisions affect our specialty don’t know who we…
Letter to the Editor
Feedback from our Readers
The Rheumatologist Revamps Its Website
The latest in rheumatology at your fingertips
How a Rheumatologist Thinks: Cognition and Diagnostic Errors in Rheumatology
The Institute of Medicine has reported that each year up to 98,000 deaths result from iatrogenic injury and error.1 Autopsy series have suggested a 15% error rate in the practice of medicine. These numbers are surprising and concerning and raise important questions about how we practice medicine. What kind of errors do we make as…
Is Acupuncture for Pain a Placebo Treatment?
An examination of the evidence
No Clear Connection Between Inflammation & Disease Progression in AS
TNF blockers decrease symptoms but seem to have little impact on structural damage
Ethics Forum: Understanding the Challenges in Rheumatology Today
Understanding the challenges in rheumatology today
- « Previous Page
- 1
- …
- 725
- 726
- 727
- 728
- 729
- …
- 811
- Next Page »